| Catalog No. | Size | Price (USD) |
| 10244-T16-50 | 50 µL | $147.96 |
| 10244-T16-100 | 100 µL | $251.64 |
| 10244-T16-200 | 200 µL | $355.32 |
General Information
| Product name | Anti-Fas Ligand/TNFSF6 Antibody, Rabbit Polyclonal |
| Validated applications | ELISA (FAQ Protocol) |
| Species reactivity | Reacts with: Human |
| Specificity | Human Fas Ligand/TNFSF6 |
| Immunogen | Recombinant Human Fas Ligand/FASLG Protein (Catalog#10244-H07Y) |
| Preparation | Produced in rabbits immunized with purified, recombinant Human Fas Ligand/FASLG (rh Fas Ligand/FASLG; Catalog#10244-H07Y; NP_000630.1; Pro134-Leu281). Fas Ligand/FASLG specific IgG was purified by Human Fas Ligand/FASLG affinity chromatography. |
| Source | Polyclonal Rabbit IgG |
| Purification | Protein A & Antigen Affinity |
| Formulation | PBS, pH7.0 with 0.03% Proclin300 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Avoid repeated freeze-thaw cycles. |
Synonyms: Anti-ALPS1B Antibody; Anti-APT1LG1 Antibody; Anti-APTL Antibody; Anti-CD178 Antibody; Anti-CD95-L Antibody; Anti-CD95L Antibody; Anti-FASL Antibody; Anti-TNFSF6 Antibody; Anti-TNLG1A Antibody
Background Information
| Full Name | Fas ligand |
| Description | Fas Ligand, also known as FASLG and CD95L, is the ligand for FAS. It is a transmembrane protein which binds to TNFRSF6/FAS. Interaction of FAS with fas Ligand is critical in triggering apoptosis of some types of cells such as lymphocytes. Fas Ligand may be involved in cytotoxic T-cell mediated apoptosis and in T-cell development. TNFRSF6/FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. |
| Related Pathways |
|
| References |
|
